Mode VC
Carol Suh

Carol Suh

Partner atArch Venture PartnersFirm active Sep 28Illinois
Arch Venture Partners websiteFirm profile

Carol Suh is a Partner at ARCH Venture Partners, joining in 2018 and promoted in 2021. She co-founded Orbital Therapeutics and Neumora Therapeutics, and invests in biotech companies.

What Carol can write

Writes checks of$25K to $30M+
Comes in atPre-seed, Seed, Series A, Series BCan lead the round
Ownership target7-10%At first check
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Arch Venture Partners writes $25K to $30M+ checks, larger than 1% of firms in the atlas.

Bars: how many firms report each check band. Highlighted: Arch Venture Partners.

Career

  1. GlaxoSmithKline · R&D Strategy
  2. Trinity Partners · Consultant
  3. ARCH Venture Partners · Associate
    Now
  4. ARCH Venture Partners · Partner
    Now

Companies founded

Orbital TherapeuticsNeumora Therapeutics

Investments named in public bios

HI-Bio

Focus

cell and gene therapyneuroscienceoncologyimmunology

Education

Harvard University, A.B. in molecular and cellular biologyYale University, M.Phil

Also at Arch Venture Partners

Paul Berns
Paul BernsManaging Director
Keith CrandellCo-Founder & Managing Director
Kristina BurowManaging Director
Mark McDonnellManaging Director
Robert NelsenCo-Founder & Managing Director
Steve GillisManaging Director
Brian Cuneo
Brian CuneoSenior Partner
Corey Ritter
Corey RitterPartner

Partners like Carol

At firms with a similar stage, sector and check size.

Jim Vaughan
Jim VaughanManaging Principal & Co-Founder, VCapital
Ali Tamaseb
Ali TamasebGeneral Partner, DCVC
Jinlin WangPartner, Foothill Ventures
Arunas ChesonisManaging Partner, Safar Partners
Wally WangFounding Partner, SAV (Scale Asia Ventures)
Ann DeWitt
Ann DeWittGeneral Partner, The Engine

Alert me when Arch Venture Partners is active

One email when Carol's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Carol Suh?

Carol Suh is a Partner at ARCH Venture Partners, joining in 2018 and promoted in 2021. She co-founded Orbital Therapeutics and Neumora Therapeutics, and invests in biotech companies.

How much does Carol Suh invest?

Carol Suh invests through Arch Venture Partners, which writes checks of $25K to $30M+ at pre-seed, seed, series a, series b.

How do I pitch Carol Suh?

A warm intro from a founder Arch Venture Partners backed works best.

What did Carol Suh do before Arch Venture Partners?

R&D Strategy at GlaxoSmithKline; Consultant at Trinity Partners.

Last updated 2026-10-15. Is this you? Ask for a correction.